Characteristics of Resistant Hypertension in a Large, Ethnically Diverse Hypertension Population of an Integrated Health System

被引:141
作者
Sim, John J. [1 ]
Bhandari, Simran K. [1 ]
Shi, Jiaxiao [2 ]
Liu, In Lu A. [2 ]
Calhoun, David A. [3 ]
McGlynn, Elizabeth A. [4 ]
Kalantar-Zadeh, Kamyar [5 ]
Jacobsen, Steven J. [2 ]
机构
[1] Kaiser Permanente, Los Angeles Med Ctr, Div Nephrol & Hypertens, Los Angeles, CA 90027 USA
[2] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA
[3] Univ Alabama, Dept Cardiovasc Med, Tuscaloosa, AL 35487 USA
[4] Kaiser Permanente, Ctr Effectiveness & Safety Res, Pasadena, CA USA
[5] Univ Calif Irvine, Sch Med, Med Ctr, Div Nephrol & Hypertens, Irvine, CA 92717 USA
基金
美国国家卫生研究院;
关键词
BLOOD-PRESSURE CONTROL; UNITED-STATES; PREVALENCE; COMMITTEE; LOSARTAN; OUTCOMES;
D O I
10.1016/j.mayocp.2013.06.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate the prevalence of and characterize resistant hypertension in a large representative population with successful hypertension management and reliable health information. Patient and Methods: We performed a cross-sectional study using clinical encounter, laboratory, and administrative information from the Kaiser Permanente Southern California health system between January 1, 2006, and December 31, 2007. From individuals older than 17 years with hypertension, resistant hypertension was identified and prevalence was determined. Multivariable logistic regression was used to calculate odds ratios (ORs), with adjustments for demographic characteristics, clinical variables, and medication use. Results: Of 470,386 hypertensive individuals, 60,327 (12.8%) were identified as having resistant disease, representing 15.3% of those taking medications. Overall, 37,061 patients (7.9%) had uncontrolled hypertension while taking 3 or more medicines. The ORs (95% CIs) for resistant hypertension were greater for black race (1.68 [1.62-1.75]), older age (1.11 [1.10-1.11] for every 5-year increase), male sex (1.06 [1.03-1.10]), and obesity (1.46 [1.42-1.51]). Medication adherence rates were higher in those with resistant hypertension (93% vs 89.8%; P<.001). Chronic kidney disease (OR, 1.84; 95% CI, 1.78-1.90), diabetes mellitus (OR, 1.58; 95% CI, 1.53-1.63), and cardiovascular disease (OR, 1.34; 95% CI, 1.30-1.39) were also associated with higher risk of resistant hypertension. Conclusion: In a more standardized hypertension treatment environment, we observed a rate of resistant hypertension comparable with that of previous studies using more fragmented data sources. Past observations have been limited due to nonrepresentative populations, reliability of the data, heterogeneity of the treatment environments, and less than ideal control rates. This cohort, which was established using an electronic medical record-based approach, has the potential to provide a better understanding of resistant hypertension and outcomes. (c) 2013 Mayo Foundation for Medical Education and Research
引用
收藏
页码:1099 / 1107
页数:9
相关论文
共 36 条
[1]   Inadequate management of blood pressure in a hypertensive population [J].
Berlowitz, DR ;
Ash, AS ;
Hickey, EC ;
Friedman, RH ;
Glickman, M ;
Kader, B ;
Moskowitz, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (27) :1957-1963
[2]   25-Hydroxyvitamin D Levels and Hypertension Rates [J].
Bhandari, Simran K. ;
Pashayan, Shahe ;
Liu, In Lu A. ;
Rasgon, Scott A. ;
Kujubu, Dean A. ;
Tom, Thomas Y. ;
Sim, John J. .
JOURNAL OF CLINICAL HYPERTENSION, 2011, 13 (03) :170-177
[3]   Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial [J].
Black, HR ;
Elliott, WJ ;
Grandits, G ;
Grambsch, P ;
Lucente, T ;
White, WB ;
Neaton, JD ;
Grimm, RH ;
Hansson, L ;
Lacourcière, Y ;
Muller, J ;
Sleight, P ;
Weber, MA ;
Williams, G ;
Wittes, J ;
Zanchetti, A ;
Anders, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (16) :2073-2082
[4]   Resistant hypertension [J].
Calhoun, DA ;
Zaman, MA ;
Nishizaka, MK .
CURRENT HYPERTENSION REPORTS, 2002, 4 (03) :221-228
[5]   Resistant hypertension: Diagnosis, evaluation, and treatment - A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [J].
Calhoun, David A. ;
Jones, Daniel ;
Textor, Stephen ;
Goff, David C. ;
Murphy, Timothy P. ;
Toto, Robert D. ;
White, Anthony ;
Cushman, William C. ;
White, William ;
Sica, Domenic ;
Ferdinand, Keith ;
Giles, Thomas D. ;
Falkner, Bonita ;
Carey, Robert M. .
HYPERTENSION, 2008, 51 (06) :1403-1419
[6]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[7]   Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease [J].
Cooper-DeHoff, Rhonda M. ;
Gong, Yan ;
Handberg, Eileen M. ;
Bavry, Anthony A. ;
Denardo, Scott J. ;
Bakris, George L. ;
Pepine, Carl J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (01) :61-68
[8]   High prevalence of cardiac and extracardiac target organ damage in refractory hypertension [J].
Cuspidi, C ;
Macca, G ;
Sampieri, L ;
Michev, I ;
Salerno, M ;
Fusi, V ;
Severgnini, B ;
Meani, S ;
Magrini, F ;
Zanchetti, A .
JOURNAL OF HYPERTENSION, 2001, 19 (11) :2063-2070
[9]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[10]   Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy [J].
Dahlof, B ;
Zanchetti, A ;
Diez, J ;
Nicholls, MG ;
Yu, CM ;
Barrios, V ;
Aurup, P ;
Smith, RD ;
Johansson, M .
JOURNAL OF HYPERTENSION, 2002, 20 (09) :1855-1864